Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Descriptive Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients - An Observational Retrospective Study

NCT06574984 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT06574984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06574984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Descriptive Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients - An Observational Retrospective Study
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
November 10, 2024
Completion date
November 4, 2025
Enrollment
329 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a